Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Dual Therapy vs Standard Triple Therapy for H. pylori Eradication
NCT03802318Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of rabeprazole and amoxicillin in Helicobacter pylori infection (4 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Helicobacter pylori eradication rate. Status: unknown.
02
Drugs
rabeprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03802318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03802318.